Thornburg Investment Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-90,516
Closed -$15.6M 202
2022
Q1
$15.6M Sell
90,516
-5,266
-5% -$787K 0.2% 90
2021
Q4
$15.5M Sell
95,782
-17,300
-15% -$2.78M 0.18% 101
2021
Q3
$16.9M Sell
113,082
-6,108
-5% -$1.27M 0.21% 89
2021
Q2
$29.2M Sell
119,190
-11,461
-9% -$3.01M 0.34% 68
2021
Q1
$34.6M Buy
130,651
+35,514
+37% +$10M 0.4% 57
2020
Q4
$27.9M Buy
+95,137
New +$24.4M 0.33% 71

Other funds holding AMED

Thornburg Investment Management's AMED Position: Q2 2022 in Review

Thornburg Investment Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 90,516 shares — an estimated $15.6M sold.

Thornburg Investment Management first reported a position in AMED in Q4 2020 and held it in 6 quarters. The position peaked at $34.6M in Q1 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Thornburg Investment Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Thornburg Investment Management sold 90,516 Amedisys shares in Q2 2022, an estimated $15.6M.
  • Thornburg Investment Management first reported a position in Amedisys in Q4 2020 and held it in 6 quarters.
  • Thornburg Investment Management's Amedisys position peaked at $34.6M in Q1 2021.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Thornburg Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.